Bright Minds Biosciences Inc. Common Stock (DRUG)
Bright Minds Biosciences Inc. Common Stock (DRUG) is listed on Nasdaq, where it has traded since March 8, 2021.
- Listed On
- Nasdaq
- Listed Since
- March 8, 2021
- Employees
- 25
- Market Cap
- $546M
About Bright Minds Biosciences Inc. Common Stock
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 98 institutions reported holding DRUG, with 9.3 million shares worth $653.8 million in aggregate. The largest reported holder was Janus Henderson (Jupiter Topco), with 1.3 million shares worth $94.8 million. Of the 5 largest holders listed below, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Janus Henderson (Jupiter Topco) | 1,349,107 | $95M | Added 5.04% |
| Cormorant Asset Management | 900,000 | $63M | Reduced 15.04% |
| BlackRock | 686,184 | $48M | Added 10.33% |
| Vivo Capital | 557,172 | $39M | Unchanged |
| Vestal Point Capital | 545,000 | $38M | Added 10.7% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is DRUG?
Bright Minds Biosciences Inc. Common Stock (DRUG) is listed on Nasdaq, where it has traded since March 8, 2021.
Who are the largest institutional holders of DRUG?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of DRUG were Janus Henderson (Jupiter Topco), Cormorant Asset Management and BlackRock.
How many institutions own DRUG?
98 institutions reported a position in DRUG for the quarter ended June 30, 2026, worth $653.8 million in total.
Did institutions buy or sell DRUG last quarter?
Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for DRUG.
Every reported institutional holder, plus insider and congressional trades in DRUG, on SentiSense.